The implications of HIV treatment on the HIV-malaria coinfection dynamics : a modeling perspective by Nyabadza, F. et al.
Research Article
The Implications of HIV Treatment on the HIV-Malaria
Coinfection Dynamics: A Modeling Perspective
F. Nyabadza,1 B. T. Bekele,2 M. A. Rúa,3 D. M. Malonza,4 N. Chiduku,5 and M. Kgosimore6
1Department of Mathematical Science, University of Stellenbosch, South Africa
2South African Centre for Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, South Africa
3Department of Biology, University of Mississippi, USA
4Department of Mathematics, Kenyatta University, Kenya
5Department of Applied Mathematics, National University of Science and Technology, Zimbabwe
6Department of Basic Sciences, Botswana College of Agriculture, Botswana
Correspondence should be addressed to F. Nyabadza; f.nyaba@gmail.com
Received 8 November 2014; Revised 24 June 2015; Accepted 1 July 2015
Academic Editor: Benoıˆt Stijlemans
Copyright © 2015 F. Nyabadza et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Most hosts harbor multiple pathogens at the same time in disease epidemiology. Multiple pathogens have the potential for
interaction resulting in negative impacts on host fitness or alterations in pathogen transmission dynamics. In this paper we develop
a mathematical model describing the dynamics of HIV-malaria coinfection. Additionally, we extended our model to examine the
role treatment (of malaria and HIV) plays in altering populations’ dynamics. Our model consists of 13 interlinked equations which
allow us to explore multiple aspects of HIV-malaria transmission and treatment. We perform qualitative analysis of the model
that includes positivity and boundedness of solutions. Furthermore, we evaluate the reproductive numbers corresponding to the
submodels and investigate the long term behavior of the submodels. We also consider the qualitative dynamics of the full model.
Sensitivity analysis is done to determine the impact of some chosen parameters on the dynamics of malaria. Finally, numerical
simulations illustrate the potential impact of the treatment scenarios and confirm our analytical results.
1. Introduction
The existence of parasites and pathogens has been doc-
umented in every free-living species [1–3]. Furthermore,
most hosts are infected with multiple species of pathogenic
organisms, leading to individual hosts which are coinfected
[4, 5]. Coinfection occurswhen two ormore pathogen species
exist within an individual at the same time [4]. Thus, the
potential for interaction among cooccurring pathogens may
result in major consequences for both the host and pathogen
populations via negative impacts on host fitness or by altering
pathogen transmission [5, 6].
Studies of coinfections with pathogens that impact
humans have provided the most comprehensive exploration
of the change of effects of coinfecting pathogens. Human
Immunodeficiency Virus (HIV) and Acquired Immunodefi-
ciency Syndrome (AIDS) represents one pathogen which has
been documented to be particularly sensitive to coinfections.
Specifically, increases in viral load as a result of recurrent or
persistent coinfections, such as occuring when individuals
are infected with both HIV/AIDS and malaria, tuberculosis,
herpes simplex virus type 2, or helminths, may facilitate
the increase in HIV transmission at both individual and
population levels [7, 8].
The bidirectional and synergistical interactions of HIV
and Malaria is particularly concerning because because of
the geographic overlap between these two diseases in the
Sub-Saharan region of Africa. In 2013, approximately 1.5
million (1.3 million–1.6 million) adults and children became
infected withHIV [9].Malaria epidemics are also widespread
in this region where it is estimated that there were 198
million cases of malaria in 2013 and an estimated 584,000
deaths [10]. Furthermore, in the year 2010, an estimated 216
million clinical episodes of malaria and 650,000 deaths were
registered in the world. Africa has the biggest disease burden,
where an estimated 91% of deaths occur in this region [11].
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Since both diseases are endemic to this region, and the time
scale of infection for both diseases can be several years, the
issue of coinfection plays a prominent role in understanding
disease dynamics for this region [12]. Recent theoretical
analyses examining the relationship between malaria and
HIV in Sub-Saharan Africa indicate that malaria dispropor-
tionately contributes to the increase in incidence of HIV in
the region [13]. In fact, without the amplification effect caused
by malaria, HIV decreases to extinction [13]. Furthermore,
empirical evidence demonstrates that individuals who live
in areas with high rates of the malaria parasite Plasmodium
falciparum have approximately twice the risk of being HIV
positive comparedwith individuals who live in areas with low
P. falciparum parasite rates [14]. Despite the importance of
understanding coinfection dynamics of these two diseases,
theoretical models exploring these relationships indicate a
large amount of change of variation surrounding the possible
outcome of HIV/AIDS-malaria coinfection dynamics for
disease incidence.
Recent theoretical work examining HIV-malaria coinfec-
tions has neglected a key element of the epidemiology of
these diseases, primarily the inclusion of treatment for one
or both diseases [7]. The main objective of this study is thus
to investigate the role of HIV treatment on the dynamics
of malaria. In this study we formulate a theoretical model
to explore population dynamics of HIV/AIDS-malaria coin-
fections. We decompose the model into submodels to gain
insights into the transmission dynamics of each infection.
Additionally we extended our model to examine the role
treatment (for both malaria and HIV/AIDS) plays in altering
populations dynamics. Our model consists of 13 interlinked
equations which allow us to explore multiple aspects of
transmission and treatment. We begin by first describing
the full model; then we evaluate the individual models for
positivity and boundedness of solutions, calculate 𝑅
0
, the
basic reproduction number, and determine the stability of
both the disease-free and endemic equilibriums. Finally, we
use simulations to explore population-level disease dynamics.
2. HIV-Malaria Coinfection Model
We considered a sexually active human population subdi-
vided into the following subpopulations: being susceptible to
all pathogens (𝑆), being exposed to malaria only (𝐸
𝑀
), being
infected with malaria only (𝐼
𝑀
), being infected with HIV
only (𝐼
𝐻
), having developedAIDS (𝐴
𝐻
), being asymptomatic
for AIDS but infected with malaria (𝐼
𝐻𝑀
), and being symp-
tomatic to both AIDS and malaria (𝐴
𝐻𝑀
). In addition, we
have different states to represent the different stages of HIV
treatment: 𝑇
𝐻
and 𝑇
𝐴
represent proportion of individuals
receiving HIV treatment from 𝐼
𝐻
and 𝐴
𝐻
, respectively, and
𝑇
𝐻𝑀
and 𝑇
𝐴𝑀
are the coinfection states of the previous states
mentioned.
We assume that individuals in state𝐴
𝐻𝑀
will first receive
treatment for malaria before starting HIV treatment to min-
imize drug complication issues. We also assume the average
recovery rate from malaria is less than a week, which is fast
compared to the slow HIV dynamics, but consistent with
observed recovery values for malaria. Newly sexually active
individuals are recruited to the human population at a rate
Λ
𝐻
. Individuals in state 𝐸
𝑀
either progress to symptomatic
stage at a rate 𝑝 or recover naturally at a rate 𝜙. The rate
at which malaria infected individuals recover from malaria
is 𝛾. Here we introduce scaling parameters 𝜖
1
and 𝜖
2
for
the recovery rates from states 𝐼
𝐻𝑀
and 𝐴
𝐻𝑀
, respectively.
These parameters are assumed to be less than 1, with 𝜖
1
>
𝜖
2
to account for the fact that coinfected individuals have
compromised immune systems, whereas 𝜂
1
, 𝜂
2
, 𝜂
3
, and 𝜂
4
(each assumed to be greater than 1) scale the force of infection
term for malaria (𝜆
𝑀
) to account for individuals’ history
of HIV/AIDS infection. The rates at which HIV infected
individuals and those coinfected with malaria progress to
AIDS stages (𝐴
𝐻
and 𝐴
𝐻𝑀
, resp.) are represented by 𝛼
1
and
𝛼
2
.
Since our main interest is to study the impact of HIV
treatment on the reduction of malaria cases, we consider a
hypothetical situation where individuals are adherent to HIV
treatment. For this study, we assume that individuals who
start treatment stay in the treatment program for the rest of
their lives. Individuals die ofmalaria at a rate 𝛿
𝑀
, where 𝜏 > 1
indicates an increase in the risk of death due to coinfection
with HIV for individuals in states 𝐼
𝐻𝑀
,𝐴
𝐻𝑀
, 𝑇
𝐻𝑀
, and 𝑇
𝐴𝑀
.
Similarly, we have a scaling parameter, 𝜑 < 1, for HIV/AIDS
induced death due to treatment for 𝑇
𝐻
and 𝑇
𝐴
, where 𝛿
𝐻
is an HIV/AIDS induced death rate for individuals in 𝐼
𝐻
.
Individuals on HIV treatment coinfected with malaria can
recover from malaria at a rate 𝑞.
The mosquito population 𝑁
𝑉
is subdivided into suscep-
tible mosquitoes (𝑆
𝑉
), mosquitoes exposed to the parasite
(𝐸
𝑉
), and infectiousmosquitoes (𝐼
𝑉
). Susceptiblemosquitoes
are generated at a constant rate Λ
𝑉
and acquire malaria
infection (following effective contacts with humans infected
with malaria) at force of infection rate 𝜆
𝑉
. Mosquitoes are
assumed to suffer natural death at a rate 𝜇
𝑉
, regardless of
their infection status. Newly infected mosquitoes are moved
into the exposed class (𝐸
𝑉
) and progress to the class of
symptomatic mosquitoes (𝐼
𝑉
) following the development of
symptoms at a rate 𝜃
𝑉
.
Here we construct a system of equations tomodel the dis-
ease dynamics of HIV/AIDS and malaria. The assumptions
given above and the schematic diagrams (Figures 1 and 2)
result in the following system:
𝑑𝑆
𝑑𝑡
= Λ
𝐻
+ 𝜙𝐸
𝑀
+ 𝛾𝐼
𝑀
− (𝜆
𝑀
+ 𝜆
𝐻
+ 𝜇) 𝑆,
𝑑𝐸
𝑀
𝑑𝑡
= 𝜆
𝑀
𝑆 − (𝜙 + 𝑝 + 𝜇) 𝐸
𝑀
,
𝑑𝐼
𝑀
𝑑𝑡
= 𝑝𝐸
𝑀
− (𝛾 + 𝑤𝜆
𝐻
+ 𝜇 + 𝛿
𝑀
) 𝐼
𝑀
,
𝑑𝐼
𝐻
𝑑𝑡
= 𝜆
𝐻
𝑆 + 𝜖
1
𝛾𝐼
𝐻𝑀
− (𝜂
1
𝜆
𝑀
+ 𝜌
1
+ 𝛼
1
+ 𝜇 + 𝛿
𝐻
) 𝐼
𝐻
,
𝑑𝑇
𝐻
𝑑𝑡
= 𝜌
1
𝐼
𝐻
+ 𝑞𝑇
𝐻𝑀
− (𝛼
3
+ 𝜂
3
𝜆
𝑀
+ 𝜇 + 𝜑𝛿
𝐻
) 𝑇
𝐻
,
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Figure 1: HIV-malaria coinfection model (the human population).
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Figure 2: Vector population.
𝑑𝐴
𝐻
𝑑𝑡
= 𝛼
1
𝐼
𝐻
+ 𝜖
2
𝛾𝐴
𝐻𝑀
− (𝜂
2
𝜆
𝑀
+ 𝜌
2
+ 𝜇 + 𝛿
𝐴
) 𝐴
𝐻
,
𝑑𝑇
𝐴
𝑑𝑡
= 𝜌
2
𝐴
𝐻
+ 𝛼
3
𝑇
𝐻
+ 𝜎𝑞𝑇
𝐴𝑀
− (𝜂
4
𝜆
𝑀
+ 𝜇 + 𝜑𝛿
𝐴
) 𝑇
𝐴
,
𝑑𝐼
𝐻𝑀
𝑑𝑡
= 𝜂
1
𝜆
𝑀
𝐼
𝐻
+ 𝑤𝜆
𝐻
𝐼
𝑀
− (𝜖
1
𝛾 + 𝛼
2
+ 𝜇 + 𝜏𝛿
𝑀
) 𝐼
𝐻𝑀
,
𝑑𝐴
𝐻𝑀
𝑑𝑡
= 𝛼
2
𝐼
𝐻𝑀
+ 𝜂
2
𝜆
𝑀
𝐴
𝐻
− (𝜖
2
𝛾 + 𝜇 + 𝜏𝛿
𝐴
) 𝐴
𝐻𝑀
,
𝑑𝑇
𝐻𝑀
𝑑𝑡
= 𝜂
3
𝜆
𝑀
𝑇
𝐻
− (𝑞 + 𝛼
4
+ 𝜇 + 𝜏𝛿
𝐻
) 𝑇
𝐻𝑀
,
𝑑𝑇
𝐴𝑀
𝑑𝑡
= 𝜂
4
𝜆
𝑀
𝑇
𝐴
+ 𝛼
4
𝑇
𝐻𝑀
− (𝜎𝑞 + 𝜇 + 𝜏𝛿
𝐴
) 𝑇
𝐴𝑀
,
𝑑𝑆
𝑉
𝑑𝑡
= Λ
𝑉
− (𝜆
𝑉
+ 𝜇
𝑉
) 𝑆
𝑉
,
𝑑𝐸
𝑉
𝑑𝑡
= 𝜆
𝑉
𝑆
𝑉
− (𝜃
𝑉
+ 𝜇
𝑉
) 𝐸
𝑉
,
𝑑𝐼
𝑉
𝑑𝑡
= 𝜃
𝑉
𝐸
𝑉
− 𝜇
𝑉
𝐼
𝑉
.
(1)
The total human and vector populations are, respectively,
given by
𝑁
𝐻
= 𝑆 + 𝐸
𝑀
+ 𝐼
𝑀
+ 𝐼
𝐻
+ 𝐼
𝐻𝑀
+ 𝐴
𝐻
+ 𝐴
𝐻𝑀
+ 𝑇
𝐻
+ 𝑇
𝐴
+ 𝑇
𝐻𝑀
+ 𝑇
𝐴𝑀
,
(2)
𝑁
𝑉
= 𝑆
𝑉
+ 𝐸
𝑉
+ 𝐼
𝑉
. (3)
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Susceptible individuals get infected with HIV at a rate 𝜆
𝐻
and
with malaria at a rate 𝜆
𝑀
, where
𝜆
𝐻
= 𝛽
𝐻
𝐼
𝐻
+ 𝜃
1
𝐼
𝐻𝑀
+ 𝜃
2
𝐴
𝐻
+ 𝜃
3
𝐴
𝐻𝑀
+ 𝜃
4
𝑇
𝐻
+ 𝜃
5
𝑇
𝐴
+ 𝜃
6
𝑇
𝐻𝑀
+ 𝜃
7
𝑇
𝐴𝑀
𝑁
𝐻
,
𝜆
𝑀
= 𝛽
𝑀
𝑏
𝑀
𝐼
𝑉
𝑁
𝐻
.
(4)
Mosquitoes acquire malaria parasite from malaria infected
individuals at a rate 𝜆
𝑉
following effective transmission
probability 𝛽
𝑉
and mosquito biting rate 𝑏
𝑀
given by the
expression
𝜆
𝑉
= 𝛽
𝑉
𝑏
𝑀
𝐼
𝑀
+ 𝑞
1
𝐼
𝐻𝑀
+ 𝑞
2
𝐴
𝐻𝑀
+ 𝑞
3
𝑇
𝐻𝑀
+ 𝑞
4
𝑇
𝐴𝑀
𝑁
𝐻
, (5)
where 𝜃’s and 𝑞’s are factors indicating the differential
contribution for the HIV and malaria infection, respectively.
𝛽
𝐻
is the effective contact rate for HIV infection, 𝛽
𝑉
is the
transmission probability for mosquito infection, and 𝑏
𝑀
is
the biting rate of mosquitoes. Summary of parameters in
the HIV-malaria coinfection model is shown in Notations
section.
Before analyzing the dynamics of the full model, we
first consider the submodels (HIV-only and malaria-only)
separately.
3. HIV-Only Model
The HIV-only model is obtained by setting states of malaria
infection and coinfection equal to zero in (1) and is described
by the following equations:
𝑑𝑆
𝑑𝑡
= Λ
𝐻
− (𝜆
𝐻
+ 𝜇) 𝑆,
𝑑𝐼
𝐻
𝑑𝑡
= 𝜆
𝐻
𝑆 − (𝜌
1
+ 𝛼
1
+ 𝜇 + 𝛿
𝐻
) 𝐼
𝐻
,
𝑑𝐴
𝐻
𝑑𝑡
= 𝛼
1
𝐼
𝐻
− (𝜌
2
+ 𝜇 + 𝛿
𝐴
) 𝐴
𝐻
,
𝑑𝑇
𝐻
𝑑𝑡
= 𝜌
1
𝐼
𝐻
− (𝛼
3
+ 𝜇 + 𝜑𝛿
𝐻
) 𝑇
𝐻
,
𝑑𝑇
𝐴
𝑑𝑡
= 𝛼
3
𝑇
𝐻
+ 𝜌
2
𝐴
𝐻
− (𝜇 + 𝜑𝛿
𝐴
) 𝑇
𝐴
,
(6)
where 𝜆
𝐻
is the force of infection term given by
𝜆
𝐻
= 𝛽
𝐻
𝐼
𝐻
+ 𝜃
2
𝐴
𝐻
+ 𝜃
4
𝑇
𝐻
+ 𝜃
5
𝑇
𝐴
𝑁
𝐻
,
with 𝑁
𝐻
= 𝑆 + 𝐼
𝐻
+ 𝐴
𝐻
+ 𝑇
𝐻
+ 𝑇
𝐴
.
(7)
Model Properties. Following [15], we have the following
theorem on the positivity and invariance of system (6).
Theorem 1. (1) The regionRH given by
RH = {𝑆 (𝑡) , 𝐼𝐻 (𝑡) , 𝐴𝐻 (𝑡) , 𝑇𝐻 (𝑡) , 𝑇𝐴 (𝑡) ∈R
5
+
: 𝑁
𝐻
≤
Λ
𝐻
𝜇
}
(8)
is positively invariant and attracting with respect to model
system (6).
(2) The solutions (𝑆(𝑡), 𝐴
𝐻
(𝑡), 𝑇
𝐻
(𝑡), 𝑇
𝐴
(𝑡)) of model (6)
are positive for all 𝑡 ≥ 0 for any given nonnegative initial
conditions.
3.1. The Basic Reproduction Number, 𝑅
0𝐻
. We use the next-
generation matrix method to determine the basic reproduc-
tion number, 𝑅
0𝐻
, of the submodel.
The basic reproduction number is given by
𝑅
0𝐻
= 𝜁 (𝐹𝑉
−1
)
=
𝛽
𝐻
𝐾
(1 +
𝜃
2
𝛼
1
𝐿
+
𝜃
4
𝜌
1
𝑀
+
𝜃
5
𝛼
3
𝜌
1
𝑀𝑁
+
𝜃
5
𝛼
1
𝜌
2
𝐿𝑁
) ,
(9)
where𝐾 = 𝛿
𝐻
+𝜇+𝛼
1
+𝜌
1
, 𝐿 = 𝜇+𝛿
𝐴
+𝜌
2
,𝑀 = 𝜇+𝜑𝛿
𝐻
+𝛼
3
,
𝑁 = 𝜇 + 𝜑𝛿
𝐴
.
3.2. Stability of theDisease-Free Equilibrium. Thedisease-free
equilibrium point, 𝜀
𝐻0
of the HIV-only model, is obtained by
setting all the infectious classes to zero so that
𝜀
𝐻0
= (𝑆, 𝐼
𝐻
, 𝐴
𝐻
, 𝑇
𝐻
, 𝑇
𝐴
) = (
Λ
𝐻
𝜇
, 0, 0, 0, 0) . (10)
Local stability of 𝜀
𝐻0
is guaranteed by using Theorem 2
in [16]. However, global stability can be established using the
method first outlined in [17]. We thus have the following
theorem.
Theorem 2. The fixed point 𝑈
0
= (𝑋
∗
; 0) = (Λ
𝐻
/𝜇, 0, 0, 0, 0)
is a globally asymptotic stable equilibrium of system (6) if
𝑅
0𝐻
< 1.
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3.3. The Endemic Equilibrium. The endemic equilibrium
point of the system is given by
𝜀
∗
𝐻
= (𝑆
∗
, 𝐼
∗
𝐻
, 𝐴
∗
𝐻
, 𝑇
∗
𝐻
, 𝑇
∗
𝐴
) , (11)
where
𝑆
∗
=
Λ
𝐻
𝜇
+
𝐾Λ
𝐻
(𝑅
0𝐻
− 1)
𝜇 (𝛽
𝐻
Γ − 𝜇𝜓)
,
𝐼
∗
𝐻
=
Λ
𝐻
(𝑅
0𝐻
− 1)
𝛽
𝐻
Γ − 𝜇𝜓
,
𝐴
∗
𝐻
=
𝛼
1
Λ
𝐻
(𝑅
0𝐻
− 1)
𝐿 (𝛽
𝐻
Γ − 𝜇𝜓)
,
𝑇
∗
𝐻
=
𝜌
1
Λ
𝐻
(𝑅
0𝐻
− 1)
𝑀 (𝛽
𝐻
Γ − 𝜇𝜓)
,
𝑇
∗
𝐴
=
Λ
𝐻
(𝐿𝛼
3
𝜌
1
+𝑀𝛼
1
𝜌
2
) (𝑅
0𝐻
− 1)
𝐿𝑀𝑁(𝛽
𝐻
Γ − 𝜇𝜓)
,
(12)
with
Γ = 1 +
𝜃
2
𝛼
1
𝐿
+
𝜃
4
𝜌
1
𝑀
+
𝜃
5
𝛼
3
𝜌
1
𝑀𝑁
+
𝜃
5
𝛼
1
𝜌
2
𝐿𝑁
,
𝜓 =
𝐾
𝜇
− (1 +
𝛼
1
𝐿
+
𝜌
1
𝑀
+
𝛼
3
𝜌
1
𝑀𝑁
+
𝛼
1
𝜌
2
𝐿𝑁
) .
(13)
Remark 3. Given that𝑅
0𝐻
= 𝛽
𝐻
Γ/𝐾 is the basic reproduction
number, when 𝑅
0𝐻
= 1, 𝜀∗
𝐻
reduces to 𝜀
𝐻0
.
We use the Center Manifold Theory described in [18] to
study the local stability of the endemic equilibrium point
(close to 𝑅
0𝐻
= 1). We apply Theorem 4.1 duplicated as
Theorem A.1 in the Appendix for ease of reference. Model
system (6) can be rewritten as follows using change of
variables:
𝑑𝑋
𝑑𝑡
= 𝐹 = (𝑓
1
, 𝑓
2
, 𝑓
3
, 𝑓
4
, 𝑓
5
) , (14)
such that
𝑥
󸀠
1
(𝑡) = 𝑓
1
= Λ
𝐻
− (𝜆
𝐻
+ 𝜇) 𝑥
1
,
𝑥
󸀠
2
(𝑡) = 𝑓2 = 𝜆𝐻𝑥1 − (𝜌1 + 𝛼1 + 𝜇 + 𝛿𝐻) 𝑥2,
𝑥
󸀠
3
(𝑡) = 𝑓
3
= 𝛼
1
𝑥
2
− (𝜌
2
+ 𝜇 + 𝛿
𝐴
) 𝑥
3
,
𝑥
󸀠
4
(𝑡) = 𝑓
4
= 𝜌
1
𝑥
2
− (𝛼
3
+ 𝜇 + 𝜑𝛿
𝐻
) 𝑥
4
,
𝑥
󸀠
5
(𝑡) = 𝑓
5
= 𝛼
3
𝑥
4
+ 𝜌
2
𝑥
3
− (𝜇 + 𝜑𝛿
𝐴
) 𝑥
5
.
(15)
We choose 𝛽
𝐻
as a bifurcation parameter. It can be shown
that the Jacobian matrix at 𝛽
𝐻
= 𝛽
∗
𝐻
has a right eigenvector
associated with the zero eigenvalue. Evaluation of the right
and left eigenvectors aids the determination of the coefficients
a and b. We thus have
a =
𝑛
∑
𝑘,𝑖,𝑗=1
V
𝑘
𝑤
𝑖
𝑤
𝑗
𝜕
2
𝑓
𝑘
𝜕𝑥
𝑖
𝜕𝑥
𝑗
(0, 0) , (16)
which gives
a = − 1
Λ
𝐻
𝛽
𝐻
𝜇
3
(𝜇 + 𝜑𝛿
𝐴
)
2
(𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) (𝜇 + 𝛿
𝐴
+ 𝜌
2
) (2 (𝜇 + 𝜑𝛿
𝐴
) (𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
)
2
+ (𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) ((𝜇 + 𝜑𝛿
𝐴
) (1 + 𝜃
4
) + 𝛼
3
(1 + 𝜃
5
)) 𝜌
1
+ ((𝛼
3
+ 2 (𝜇 + 𝜑𝛿
𝐴
)) 𝜃
4
+ 𝛼
3
𝜃
5
) 𝜌
2
) (𝜇 + 𝛿
𝐴
+ 𝜌
2
)
2
+ 𝛼
2
1
(𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
)
2
(2 (𝜇 + 𝜑𝛿
𝐴
) 𝜃
2
+ (𝜃
2
+ 𝜃
5
)
⋅𝜌
2
) + 𝛼
1
(𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) (𝜇 + 𝛿
𝐴
+ 𝜌
2
) (((𝜇
+ 𝜑𝛿
𝐴
) ((𝜇 + 𝜑𝛿
𝐻
) (1 + 𝜃
2
) + (𝜃
2
+ 𝜃
4
) 𝜌
1
)
+ ((𝜇 + 𝜑𝛿
𝐻
) (1 + 𝜃
5
) + (𝜃
4
+ 𝜃
5
) 𝜌
1
) 𝜌
2
+ 𝛼
3
(𝜇
+ 𝜑𝛿
𝐴
(1 + 𝜃
2
) + 𝜃
2
(𝜇 + 𝜌
1
) + 𝜌
2
+ 𝜃
5
(𝜌
1
+ 𝜌
2
)))) .
(17)
Similarly,
b =
𝑛
∑
𝑘,𝑖=1
V
𝑘
𝑤
𝑖
𝜕
2
𝑓
𝑘
𝜕𝑥
𝑖
𝜕𝛽
𝐻
(0, 0) (18)
results in
𝑏 = 𝜇 (𝜇 + 𝜑𝛿
𝐴
) (𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) (𝜇 + 𝛿
𝐴
+ 𝜌
2
)
⋅ (𝛼
1
(𝜇 + 𝜑𝛿
𝐴
) (𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) 𝜃
2
+ (𝜇 + 𝜑𝛿
𝐴
) (𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) (𝜇 + 𝛿
𝐴
+ 𝜌
2
)
+ (𝜇 + 𝜑𝛿
𝐴
) 𝜃
4
𝜌
1
(𝜇 + 𝛿
𝐴
+ 𝜌
2
)
+ 𝜃
5
(𝛼
1
(𝜇 + 𝛼
3
+ 𝜑𝛿
𝐻
) 𝜌
2
+ 𝛼
3
𝜌
1
(𝜇 + 𝛿
𝐴
+ 𝜌
2
))) .
(19)
Thus, 𝑎 < 0 and 𝑏 > 0. We thus have the following theorem.
Theorem 4. The endemic equilibrium is locally asymptotically
stable for 𝑅
0𝐻
near 1.
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4. Malaria-Only Model
In a similar way, if we set states of HIV and coinfection equal
to zero in (1), we obtain malaria-only model described by the
following system of equations:
𝑑𝑆
𝑑𝑡
= Λ
𝐻
+ 𝜙𝐸
𝑀
+ 𝛾𝐼
𝑀
− (𝜆
𝑀
+ 𝜇) 𝑆,
𝑑𝐸
𝑀
𝑑𝑡
= 𝜆
𝑀
𝑆 − (𝜙 + 𝑝 + 𝜇) 𝐸
𝑀
,
𝑑𝐼
𝑀
𝑑𝑡
= 𝑝𝐸
𝑀
− (𝛾 + 𝜇 + 𝛿
𝑀
) 𝐼
𝑀
,
𝑑𝑆
𝑉
𝑑𝑡
= Λ
𝑉
− (𝜆
𝑉
+ 𝜇
𝑉
) 𝑆
𝑉
,
𝑑𝐸
𝑉
𝑑𝑡
= 𝜆
𝑉
𝑆
𝑉
− (𝜃
𝑉
+ 𝜇
𝑉
) 𝐸
𝑉
,
𝑑𝐼
𝑉
𝑑𝑡
= 𝜃
𝑉
𝐸
𝑉
− 𝜇
𝑉
𝐼
𝑉
.
(20)
The force of infection terms for malaria infection from
mosquito to human and vice versa is given by 𝜆
𝑀
and 𝜆
𝑉
,
respectively, where
𝜆
𝑀
= 𝛽
𝑀
𝑏
𝑀
𝐼
𝑉
𝑁
𝐻
,
𝜆
𝑉
= 𝛽
𝑉
𝑏
𝑀
𝐼
𝑀
𝑁
𝐻
.
(21)
4.1. Model Properties. The following results can easily be
established on the positivity and boundedness of the solu-
tions of system (20) in the feasible region
Ω ⊆ Ω
𝐻
× Ω
𝑉
, (22)
where
Ω
𝐻
= {(𝑆, 𝐸
𝑀
, 𝐼
𝑀
) | 𝑁
𝐻
≤
Λ
𝐻
𝜇
, 𝑆
≤
Λ
2
𝐻
𝜇
𝑉
(𝜙 + 𝛾 + 𝜇)
𝜇 (𝛽
𝑀
𝑏
𝑀
Λ
𝑉
𝜇 + (𝜙 + 𝛾 + 𝜇)Λ
𝐻
𝜇
𝑉
)
, 𝐸
𝑀
≤
𝛽
𝑀
𝑏
𝑀
Λ
𝑉
(𝜙 + 𝑝 + 𝜇)
(𝜙 + 𝑝 + 𝜇) (𝛽
𝑀
𝑏
𝑀
Λ
𝑉
𝜇 + (𝜙 + 𝛾 + 𝜇)Λ
𝐻
𝜇
𝑉
)
,
𝐼
𝑀
≥ 0} ,
Ω
𝑉
= {(𝑆
𝑉
, 𝐸
𝑉
, 𝐼
𝑉
) | 𝑁
𝑉
≤
Λ
𝑉
𝜇
𝑉
, 𝑆
𝑉
≤
Λ
𝑉
𝛽
𝑉
𝑏
𝑀
+ 𝜇
𝑉
,
𝐸
𝑉
≤
𝛽
𝑉
𝑏
𝑀
Λ
𝑉
(𝛽
𝑉
𝑏
𝑀
+ 𝜇
𝑉
) (𝜃
𝑉
+ 𝜇
𝑉
)
, 𝐼
𝑉
≥ 0} .
(23)
Theorem 5. (1)The solutions (𝑆(𝑡), 𝐸
𝑀
(𝑡), 𝐼
𝑀
(𝑡), 𝑆
𝑉
(𝑡), 𝐸
𝑉
(𝑡),
𝐼
𝑉
(𝑡)) of model (20) are positive for all 𝑡 ≥ 0 for nonnegative
initial conditions.
(2) All solutions (𝑆(𝑡), 𝐸
𝑀
(𝑡), 𝐼
𝑀
(𝑡), 𝑆
𝑉
(𝑡), 𝐸
𝑉
(𝑡), 𝐼
𝑉
(𝑡)) of
model (20) are bounded.
4.2. The Basic Reproduction Number, 𝑅
0𝑀
. The associated
basic reproduction number 𝑅
0𝑀
of the model is given by
𝑅
0𝑀
= 𝜁 (𝐹𝑉
−1
) = √𝑅
ℎ
0𝑀
𝑅
V
0𝑀
, (24)
where
𝑅
ℎ
0𝑀
=
𝑝𝛽
𝑀
𝜇
Λ
𝐻
(𝜙 + 𝑝 + 𝜇) (𝛾 + 𝜇 + 𝛿
𝑀
)
,
𝑅
V
0𝑀
=
𝑏
2
𝑀
𝛽
𝑉
𝜃
𝑉
Λ
𝑉
𝜇
2
𝑉
(𝜃
𝑉
+ 𝜇
𝑉
)
.
(25)
Here, 𝑅ℎ
0𝑀
represents the contribution from the human
population, while 𝑅V
0𝑀
represents the contribution from the
vector population.
4.3. Stability of the Disease-Free Equilibrium. We begin by
determining the disease-free equilibrium point 𝜀
𝑀0
of the
malaria-only model, by setting all the equations in (20) equal
to zero so that
𝜀
𝑀0
= (𝑆, 𝐸
𝑀
, 𝐼
𝑀
, 𝑆
𝑉
, 𝐸
𝑉
, 𝐼
𝑉
)
= (
Λ
𝐻
𝜇
, 0, 0,
Λ
𝑉
𝜇
𝑉
, 0, 0) .
(26)
Following Theorem 2 stated in [16], we present local
stability property for the disease-free equilibrium in the
following theorem.
Theorem 6. The disease-free equilibrium of system (20) is
locally asymptotically stable whenever 𝑅
0𝑀
< 1 and unstable
otherwise.
The global stability of (20) follows [17]. We thus have the
following theorem.
Theorem 7. The fixed point 𝑈
0
= (𝑋
∗
; 0) = (Λ
𝐻
/𝜇, Λ
𝑉
/𝜇
𝑉
,
0, 0, 0, 0) is a globally asymptotic stable (g.a.s) equilibrium of
system (20) if 𝑅
0𝑀
< 1.
4.4. The Endemic Equilibrium. The endemic equilibrium
point of (20) is given by
𝜀
𝑀1
= (𝑆
∗
, 𝐸
∗
𝑀
, 𝐼
∗
𝑀
, 𝑆
∗
𝑉
, 𝐸
∗
𝑉
, 𝐼
∗
𝑉
) , (27)
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where
𝑆
∗
=
(𝛾 + 𝜇 + 𝛿
𝑀
) (𝜙 + 𝑝 + 𝜇)Λ
𝐻
𝜇 (𝜙 + 𝑝 + 𝜇) 𝛾 + 𝜇 + 𝛿
𝑀
+ 𝜆
∗
𝑀
(𝜇 (𝑝 + 𝛾 + 𝜇) + (𝑝 + 𝜇) 𝛿
𝑀
)
,
𝐸
∗
𝑀
=
𝜆
∗
𝑀
Λ
𝐻
(𝛾 + 𝜇 + 𝛿
𝑀
)
𝜇 (𝜙 + 𝑝 + 𝜇) (𝛾 + 𝜇 + 𝛿
𝑀
) + 𝜆
∗
𝑀
(𝜇 (𝑝 + 𝛾 + 𝜇) + (𝑝 + 𝜇) 𝛿
𝑀
)
,
𝐼
∗
𝑀
=
𝑝𝜆
∗
𝑀
Λ
𝐻
𝜇 (𝜙 + 𝑝 + 𝜇) (𝛾 + 𝜇 + 𝛿
𝑀
) + 𝜆
∗
𝑀
(𝜇 (𝑝 + 𝛾 + 𝜇) + (𝑝 + 𝜇) 𝛿
𝑀
)
,
𝑆
∗
𝑉
=
Λ
𝑉
𝜆
∗
𝑉
+ 𝜇
𝑉
,
𝐸
∗
𝑉
=
𝜆
∗
𝑉
Λ
𝑉
(𝜆
∗
𝑉
+ 𝜇
𝑉
) (𝜃
𝑉
+ 𝜇
𝑉
)
,
𝐼
∗
𝑉
=
𝜆
∗
𝑉
Λ
𝑉
𝜃
𝑉
𝜇
𝑉
(𝜆
∗
𝑉
+ 𝜇
𝑉
) (𝜃
𝑉
+ 𝜇
𝑉
)
.
(28)
Note that
𝜆
∗
𝑀
= 𝛽
𝑀
𝑏
𝑀
𝐼
∗
𝑉
𝑁
∗
𝐻
,
𝜆
∗
𝑉
= 𝛽
𝑉
𝑏
𝑀
𝐼
∗
𝑀
𝑁
∗
𝐻
,
(29)
where𝑁∗
𝐻
= 𝑆
∗
+ 𝐸
∗
𝑀
+ 𝐼
∗
𝑀
.
Using the Center Manifold Theory [18] to study the local
stability of the endemic equilibriumpoint (very close to𝑅ℎ
0𝑀
),
we have the corresponding coefficients a and b as
a = 𝑎
+
− 𝑎
−
, (30)
where
𝑎
+
= 2𝑏
3
𝑀
𝛽
2
𝑀
𝛽
𝑉
𝜇
3
(𝑝 + 𝜇 + 𝜙) (𝛾 + 𝜇 + 𝛿
𝑀
)
⋅ 𝜃
𝑉
Λ
2
𝑉
𝜇
𝑉
(𝜃
𝑉
+ 𝜇
𝑉
)
2
(𝑏
2
𝑀
𝑝
2
𝛽
2
𝑉
𝜇
2
+ (𝜇
2
(𝑝
2
+ 𝑝 (𝛾 + 𝜇) + (𝛾 + 𝜇)
2
)
+ 𝜇 (𝑝
2
+ 2𝜇 (𝛾 + 𝜇) + 𝑝 (𝛾 + 2𝜇)) 𝛿
𝑀
+ (𝑝
2
+ 𝑝𝜇 + 𝜇
2
) 𝛿
2
𝑀
) 𝜇
2
𝑉
) ,
𝑎
−
= 𝑏
3
𝑀
𝑝𝛽
2
𝑀
𝛽
𝑉
𝜇
4
(𝑝 + 𝜇 + 𝜙) (𝛾 + 𝜇 + 𝛿
𝑀
)
⋅ 𝜃
𝑉
Λ
𝑉
𝜇
2
𝑉
(𝜃
𝑉
+ 𝜇
𝑉
)
2
(2𝑏
𝑀
𝑝𝛽
𝑉
𝛿
𝑀
Λ
𝑉
+ (𝑝 + 𝛾
+ 𝜇 + 𝛿
𝑀
) Λ
𝐻
𝜇
2
𝑉
) .
(31)
Also
b = 𝑏
𝑀
𝑝𝛽
𝑀
𝛽
𝑉
𝜇
2
(𝑝 + 𝜇 + 𝜙) (𝛾 + 𝜇 + 𝛿
𝑀
)
⋅ 𝜃
𝑉
Λ
𝑉
(𝜃
𝑉
+ 𝜇
𝑉
)
⋅ (𝛿
𝑀
Λ
𝑉
𝜇
𝑉
+ Λ
𝐻
𝜇
2
𝑉
− 2𝑏
𝑀
𝛽
𝑉
𝜇Λ
𝑉
) .
(32)
Table 1: Parameter estimation.
Parameters Current value Reference
Λ
𝐻
(1.932/365) 𝑁
ℎ0
[19]
Λ
𝑉
6𝑁V0 [20, 21]
𝛾 2.5/365 Estimate
𝜙 0.2/365 Estimate
𝑝 0.08333/365 [21, 22]
𝑤 0.9 Estimate
𝜇, 𝜇
𝑉
0.02/365, 0.1429/365 [21, 22]
𝛿
𝑀
3.54 × 10
−4 [21, 22]
𝛿
𝐻
0.05/365 Estimate
𝛿
𝐴
0.2/365 Estimate
𝑏
𝑀
0.15 Estimate
𝛽
𝑀
0.5 Estimate
𝛽
ℎ
0.567/365 Estimate
𝛽
𝑉
0.05 Estimate
𝑞 0.5/365 Estimate
𝜎 0.7 Estimate
𝛼
1,2,3,4
0.0005 each Estimate
𝜌
1,2
0.015/365 each Estimate
𝜖
1,2
0.5/365, 0.05/365 Estimate
𝜂
1,2,3,4
1.2 each Estimate
𝜃
1,2,3,4,5,6,7
0.2 each Estimate
𝑞
1,2,3,4
1 each Estimate
𝜑, 𝜏 0.5, 1.01 Estimate
𝜃
𝑉
0.1 Estimate
The signs of the coefficients above are not known; hence
we put conditions for the existence of backward bifurcation.
Lemma 8. The system exhibits backward bifurcation if the
following conditions satisfy
(i) 𝑎
+
> 𝑎
−
,
(ii) 𝛿
𝑀
Λ
𝑉
𝜇
𝑉
+ Λ
𝐻
𝜇
2
𝑉
> 2𝑏
𝑀
𝛽
𝑉
𝜇Λ
𝑉
.
Remark 9. The existence of a backward bifurcation impacts
the design of malaria control measures, since an epidemic
may persist even 𝑅ℎ<1
0𝑀
.
5. Numerical Simulations
The full model is complicated to carry out mathematical
analyses.The matrix for the full model will be 14 by 14 square
matrix. Hence we only focused on the numerical simulations
of the full model (1). The set of parameter values are given in
Table 1.
Ourmodel demonstrates interestingmathematical results
which extend to important implications for disease manage-
ment. Specifically, we show cyclical dynamics which indicate
the coexistence of malaria and HIV is dependent upon the
presence of both pathogens and is sensitive to a number
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Figure 3: Sensitivity indices for the reproduction numbers: (a) HIV-only model and (b) malaria-only model. 𝑅
0𝐻
is positively affected by
changes in 𝛽
𝐻
and 𝜃
𝑉
. Increasing the values of 𝑏
𝑀
, 𝛽
𝑀
, 𝛽
𝑉
, and 𝜃
𝑉
increases 𝑅
0𝑀
, while changes to the parameters 𝛾 and 𝜙 have opposite effect
on the value of 𝑅
0𝑀
.
of parameters which determine disease severity. We also
demonstrate the importance of treatment for maintaining
coexistence rather than disease induced extinction and fur-
ther explore the role starting treatment plays in changing
disease dynamic.
5.1. Coexistence. For our model, coexistence can only occur
when the number of new malaria cases generated from
a single malaria case is sufficiently low to sustain HIV
infected individuals. Specifically, our simulations indicate
that both HIV dynamics and malaria dynamics fluctuate but
HIV dynamics synchronize with malaria dynamics such that
population crashes as a result of malaria infections causing
the number of HIV infected individuals to decrease. This is
similar to previous work which also found the amplification
effect caused by coinfection between malaria and HIV was
responsible for maintaining HIV in Sub-Saharan Africa [14].
The importance of such fluctuationsmay further be explained
when considering the sensitivities of 𝑅
0
for the individual
diseasemodels with respect to their parameters. Interestingly,
𝑅
0
’s of our individual diseasemodels are particularly sensitive
to parameters which relate to transmission probabilities.
While𝑅
0
associated withHIV is strongly and positively influ-
enced by changes to the direct transmission parameter 𝛽
𝐻
(the contact rate between a humanwithHIVand a susceptible
human), 𝑅
0
associated with malaria is strongly and positively
influenced by changes to the indirect transmission parameter
𝑏
𝑀
(the mosquito biting rate); however, 𝑅
0
associated with
malaria is less sensitive to the direct transmission parameters
𝛽
𝑀
and 𝛽
𝑉
(the transmission probability of malaria) but
this relationship is still positive (Figure 3). Unsurprisingly,
changes in parameters associated with recovery frommalaria
(𝛾 and 𝜙) are likely to decrease 𝑅
0
associated with malaria
(Figure 3(b)). Thus alterations in the individual disease
transmission caused by coinfection with another pathogen
are likely to increase the severity of infection of one or both
diseases and alterations in the ability of an individual to
recover from malaria caused by coinfection with HIV will
also lead to increase in disease severity.
This sensitivity to 𝑅
0
may be an indicator of the role
intrahost pathogen dynamics play in altering the success of
multiple pathogens when individuals are coinfected. While
we hypothesized that the severe impairment, HIV imposes
on the host immune system, would allow malaria infection
to progress more quickly [23], it appears that HIV infection
actually acts to increase the rate at which individuals move
from the malaria exposed class to the malaria infected class
for malaria only which lowers the overall 𝑅
0
for the system.
This increase in disease progressionmay explain whymalaria
treatment is more likely to fail for HIV-infected individuals
[24, 25] and help explain why patients infected with both
malaria and HIV are more likely to experience symptoms
associated with severe/complicated malaria [26], but further
work is needed to confirm this mechanism. Additionally,
we demonstrate similar dynamics with mosquitoes such that
coinfection hinders disease progression of malaria when
mosquitoes feed on hosts infectedwith bothHIV andmalaria
(Figure 4). This suggests that the HIV RNA virus is interact-
ing with the malaria parasite Plasmodium to alter its success
in both the host and the vector, supporting previous research
which indicates intrahost dynamics play an important role in
explaining the effects of malaria-HIV coinfection [27].
Our model indicates an important relationship between
HIV/AIDS and malaria infection such that the number of
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Figure 4: Plots for the vector population: (a) susceptible (𝑆
𝑉
), (b) exposed (𝐸
𝑉
), and (c) infected (𝐼
𝑉
) vectors. Here the source of malaria
infection is assumed to be only from malaria infected patients.
HIV infected individuals peaks earlier when individuals are
singularly infected with HIV/AIDS (Figures 5(a) and 5(c))
compared to when they are coinfected with HIV or AIDS
(Figures 5(b) and 5(d)). In other words, in our model, the
presence of malaria delays the start of infections dynamics
of HIV but speeds up the progression of the disease. This
suggests that coinfection with malaria can be especially
detrimental to those individuals infected with HIV/AIDS,
possibly as a result of increases in viral load which result from
coinfection [28].
5.2. Treatment. Our model also has important implications
for treatment as it indicates a key interaction between the
rate of treatment for HIV/AIDS and malaria infection such
that the number of HIV infected individuals decreases in all
classes when individuals are on treatment (Figure 6) com-
pared to when individuals are not on treatment (Figure 5).
Specifically, this translates to a decrease in the number of new
HIV infections (Figure 7(a)) and the number of new malaria
cases (Figure 7(b)) for individuals receiving treatment com-
pared to individuals who do not receive treatment. This is
especially important for individuals coinfected with AIDS
and malaria as increasing the rate individuals start treatment
(𝜌) decreases the number of infected individuals (Figure 8).
Interestingly, treatment for individuals only infected with
AIDS leads to a stable equilibrium earlier than when indi-
viduals with AIDS do not receive treatment (Figures 5(c)
and 6(c)). Such results strongly suggest that increasing the
availability and effectiveness of treatment for HIV will help
dampen not only HIV/AIDS dynamics but also decrease the
severity of malaria infection.
Furthermore, similar dynamics occur with malaria.
While we did not specifically account for treatment of
malaria, we did allow for individuals with malaria to recover
naturally. Perhaps unsurprisingly, increasing this rate (𝛾)
decreases 𝑅
0
specific to malaria (Figure 9).
When HIV is considered independently of malaria, we
see that treatment does not significantly alter the HIV preva-
lence in the population, but it does alter disease dynamics
such that increasing the rate at which individuals start
treatment (𝜌) can slightly delay increases in population
prevalence over time but does not alter the duration for
infection (Figure 10).
Similarly, when malaria infection is considered indepen-
dently of HIV, we see that treatment does not significantly
alter the number of malaria cases in the population, but it
does alter disease dynamics such that increasing the rate
at which individuals start treatment (𝜌) can slightly delay
increases in population prevalence over time but does not
alter the duration for infection (Figure 11).
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Figure 5: Plots for individuals not onHIV treatment as we vary the progression rate from exposed tomalaria infected. HIV, 𝐼
𝐻
(a); coinfected
with HIV and malaria, 𝐼
𝐻𝑀
(b); infected with AIDS, 𝐴
𝐻
(c); coinfected with AIDS and malaria, 𝐴
𝐻𝑀
(d). Only the number of coinfected
individuals varies as we vary 𝜌. In panel (d), increases in the thickness of the line indicate increases in parameter 𝜌 (progress rate from exposed
to malaria infected classes).
6. Conclusion
Our model emphasizes the importance of considering HIV-
malaria coinfection when considering disease dynamics in
Sub-Saharan Africa. We further demonstrate amplification
in HIV/AIDS prevalence as a result of malaria coinfection;
however, we also demonstrate the importance of treatment
for mitigating this dynamic, especially for AIDS infected
patients. Therefore, we advocate for continued efforts to
increase access to treatment as a means of mitigating the
harmful effects of malaria-HIV coinfection.
Although our model represents a significant step for-
ward in modeling the interaction of HIV/AIDS dynamics
with malaria dynamics by including treatment, it is limited
in a few ways. First, for individuals coinfected with both
pathogens, HIV infection always occurs prior to acquiring
malaria. This limits our ability to infer whether individuals
who have malaria and then acquire HIV demonstrate the
same dynamics; thus, future theoretical work is needed to
explore this phenomenon. Second, our model is limited by
parameterization. While we were able to acquire some of
our parameter values from the literature, we had to estimate
many of the other parameters.This may influence simulation
dynamics. Consequently, we encourage future collaborative
research with empiricists to develop experiments which
will explicitly measure some of the parameters which are
currently estimates in order to better inform future models.
Despite these shortcomings, the model presents some
interesting results on the benefits ofHIV treatment tomalaria
control. This is particularly important in Sub-Saharan Africa
where the coexistence of Malaria and HIV/AIDS is more
conspicuous.
Appendix
Center Manifold Theory
We apply Center Manifold Theory (CMT) as described in
[18] to establish the local stability of an endemic equilibrium
point and check for the existence of backward bifurcation. It
is applicable in deciding the local stability of a nonhyperbolic
equilibrium (linearisation matrix which has at least one
eigenvalue with a zero real part). The theory determines not
only the local stability of the nonhyperbolic equilibrium but
also the existence of a backward bifurcation. We duplicate
Theorem 4.1 in [18] for the convenience of the reader.
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specific to malaria as a function of increasing the rate
at which individuals recover from malaria naturally (𝛾).
Consider a general system of differential equations with
parameter Φ (which will be considered as a bifurcation
parameter):
𝑑𝑥
𝑑𝑡
= 𝑓 (𝑥,Φ) ,
𝑓 : R
𝑛
×R → R
𝑛
, 𝑓 ∈ C
2
(R
𝑛
×R) .
(A.1)
Without loss of generality, it is assumed that 0 is an equilib-
rium for system for all values of parameterΦ; that is,
𝑓 (0, Φ) ≡ 0, ∀Φ. (A.2)
We state the theorem as follows.
Theorem A.1. Assume the following.
(1) 𝐴 = 𝐷
𝑥
𝑓(0, 0) = ((𝜕𝑓
𝑖
/𝜕𝑥
𝑗
)(0, 0)) is the linearisation
matrix of system around equilibrium 0 with Φ evalu-
ated at 0. Zero is a simple eigenvalue of A and all other
eigenvalues of 𝐴 have negative real parts.
0 5 10 15 20 25 30 35 40 45 50
0
5
10
15
20
25
30
35
40
45
H
IV
 p
re
va
le
nc
e (
%
)
Time (years)
Figure 10: HIV prevalence (number of infected individuals/total
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rate at which individuals start treatment (𝜌).
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function of time. The thicker the curve, the larger the rate at which
individuals start treatment (𝜌).
(2) Matrix 𝐴 has a nonnegative right eigenvector 𝑤 and a
left eigenvector V corresponding to the zero eigenvalue.
Let 𝑓
𝑘
be the 𝑘th component of 𝑓 and
𝑎 =
𝑛
∑
𝑘,𝑖,𝑗=1
V
𝑘
𝑤
𝑖
𝑤
𝑗
𝜕
2
𝑓
𝑘
𝜕𝑥
𝑖
𝜕𝑥
𝑗
(0, 0) ,
𝑏 =
𝑛
∑
𝑘,𝑖=1
V
𝑘
𝑤
𝑖
𝜕
2
𝑓
𝑘
𝜕𝑥
𝑖
𝜕Φ
(0, 0) .
(A.3)
The local dynamics of (A.1) around 0 are totally determined by
a and b.
(1) Consider 𝑎 > 0, 𝑏 > 0. When Φ < 0 with |Φ| ≪ 1, 0 is
locally asymptotically stable, and there exists a positive
unstable equilibrium; when 0 < Φ ≪ 1, 0 is unstable
and there exists a negative and locally asymptotically
stable equilibrium.
(2) Consider 𝑎 < 0, 𝑏 < 0. When Φ < 0 with |Φ| ≪ 1, 0 is
unstable; when 0 < Φ ≪ 1, 0 is locally asymptotically
stable, and there exists a positive unstable equilibrium.
(3) Consider 𝑎 > 0, 𝑏 < 0. When Φ < 0 with |Φ| ≪ 1, 0 is
unstable, and there exists a locally asymptotically stable
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negative equilibrium; when 0 < Φ ≪ 1, 0 is stable, and
a positive unstable equilibrium appears.
(4) Consider 𝑎 < 0, 𝑏 > 0. When Φ < 0 changes
from negative to positive, 0 changes its stability from
stable to unstable. Correspondingly a negative unstable
equilibriumbecomes positive and locally asymptotically
stable.
Notations
Λ
𝐻
: New recruitment to the human population
𝛾: Recovery rate from malaria infected class
𝜙: Recovery rate from malaria exposed class
𝑝: Progress rate from exposed to malaria
infected
𝑤: Relative reduction to HIV infection for 𝐼
𝑀
𝜇, 𝜇
𝑉
: Natural mortality rate for human,
mosquito population, respectively
𝛿
𝑀
: Malaria induced mortality rate for
individuals in state 𝐼
𝑀
𝛿
𝐻
: HIV/AIDS induced mortality rate for
individuals in state 𝐼
𝐻
𝛿
𝐴
: HIV/AIDS induced mortality rate for
individuals in state 𝐴
𝐻
𝛽
𝐻
: HIV transmission probability
𝑏
𝑀
: The biting rate of mosquitoes
𝛽
𝑀
: The transmission probability per bite from
vector to human
𝛽
𝑉
: The transmission probability per bite from
human to vector
𝑞: Recovery rate from malaria for coinfected
individuals
𝜎: A factor which accounts for differential
recovery rate from malaria
𝛼
1,2,3,4
: Progression rates to AIDS stage
𝜌
1,2
: Rates at which individuals start treatment
𝜖
1,2
: Factors which account for differential
recovery rates
𝜂
1,2,3,4
: Factors which account for differential
malaria infection rates
𝜃
1,2,3,4,5,6,7
: Factors indicating the differential
contribution for the HIV infection rates
𝑞
1,2,3,4
: Factors indicating the differential
contribution for the malaria infection rates
𝜑, 𝜏: Factors which account for differential
AIDS induced death
𝜃
𝑉
: The rate at which mosquitoes progress to
infectious state.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] A. Dobson, K. D. Lafferty, A. M. Kuris, R. F. Hechinger, and
W. Jetz, “Homage to Linnaeus: howmany parasites? Howmany
hosts?” Proceedings of the National Academy of Sciences of the
United States of America, vol. 105, no. 1, pp. 11482–11489, 2008.
[2] K.D. Lafferty, S. Allesina,M.Arim et al., “Parasites in foodwebs:
the ultimate missing links,” Ecology Letters, vol. 11, no. 6, pp.
533–546, 2008.
[3] C. L. Nunn, S. Altizer, K. E. Jones, and W. Sechrest, “Compara-
tive tests of parasite species richness in primates,”TheAmerican
Naturalist, vol. 162, no. 5, pp. 597–614, 2003.
[4] A. L. Graham, I. M. Cattadori, J. O. Lloyd-Smith, M. J.
Ferrari, and O. N. Bjørnstad, “Transmission consequences of
coinfection: cytokines writ large?” Trends in Parasitology, vol.
23, no. 6, pp. 284–291, 2007.
[5] M. E. Hood, “Dynamics of multiple infection and within-
host competition by the anther-smut pathogen,” American
Naturalist, vol. 162, no. 1, pp. 122–133, 2003.
[6] B. Koskella, T. Giraud, and M. E. Hood, “Pathogen relatedness
affects the prevalence of within-host competition,” American
Naturalist, vol. 168, no. 1, pp. 121–126, 2006.
[7] R. V. Barnabas, E. L. Webb, H. A. Weiss, and J. N. Wasserheit,
“The role of coinfections in HIV epidemic trajectory and
positive prevention: a systematic review and meta-analysis,”
AIDS, vol. 25, no. 13, pp. 1559–1573, 2011.
[8] K. Modjarrad and S. H. Vermund, “Effect of treating co-
infections on HIV-1 viral load: a systematic review,”The Lancet
Infectious Diseases, vol. 10, no. 7, pp. 455–463, 2010.
[9] UNAIDS, “Beginning of the end of the aids epidemic,” UNAIDS
Gap Report, UNAIDS, 2013, http://www.unaids.org/.
[10] Malaria, Fact sheet no. 94, 2013, http://www.who.int/mediacen-
tre/factsheets/fs094/en/.
[11] CDC, Malaria facts, 2013, http://www.cdc.gov/malaria/.
[12] J.-P. Van geertruyden and U. D’Alessandro, “Malaria and HIV: a
silent alliance,” Trends in Parasitology, vol. 23, no. 10, pp. 465–
467, 2007.
[13] D. F. Cuadros, P. H. Crowley, B. Augustine, S. L. Stewart,
and G. Garc´ıa-Ramos, “Effect of variable transmission rate on
the dynamics of HIV in sub-Saharan Africa,” BMC Infectious
Diseases, vol. 11, article no. 216, 2011.
[14] D. F. Cuadros, A. J. Branscum, and P. H. Crowley, “HIV–malaria
co–infection: effects of malaria on the prevalence of HIV in east
sub–saharan Africa,” International Journal of Epidemiology, vol.
40, no. 4, pp. 931–939, 2011.
[15] F. Nyabadza, C. Chiyaka, and Z. Mukandavire, “Analysis of an
HIV/AIDS model with public-health information campaigns
and individual withdrawal,” Journal of Biological Systems, vol.
18, no. 2, pp. 357–375, 2010.
[16] P. van denDriessche and J.Watmough, “Reproduction numbers
and sub-threshold endemic equilibria for compartmental mod-
els of disease transmission,”Mathematical Biosciences, vol. 180,
pp. 29–48, 2002.
[17] C. Castillo-Chavez, Z. Feng, and W. Huang, “On the compu-
tation of 𝑅
0
and its role on global stability,” in Mathematical
Approaches for Emerging and Reemerging Infectious Diseases: An
introduction, Springer, Berlin, Germany, 2002.
[18] C. Castillo-Chavez and B. Song, “Dynamical models of tuber-
culosis and their applications,” Mathematical Biosciences and
Engineering, vol. 1, no. 2, pp. 361–404, 2004.
[19] Central Intelligence Agency, Birth Rate—CIA—TheWorld Fact-
book, 2012, https://www.cia.gov/library/publications.
[20] C. Chiyaka, W. Garira, and S. Dube, “Effects of treatment and
drug resistance on the transmission dynamics of malaria in
14 BioMed Research International
endemic areas,”Theoretical Population Biology, vol. 75, no. 1, pp.
14–29, 2009.
[21] Z. Mukandavire, A. B. Gumel, W. Garira, and J. M. Tchuenche,
“Mathematical analysis of a model for HIV-malaria co-
infection,”Mathematical Biosciences and Engineering, vol. 6, no.
2, pp. 333–362, 2009.
[22] N. Chitnis, J. M. Cushing, and J. M. Hyman, “Bifurcation
analysis of a mathematical model for malaria transmission,”
SIAM Journal on Applied Mathematics, vol. 67, no. 1, pp. 24–45,
2006.
[23] L. Slutsker and B. J. Marston, “HIV and malaria: interactions
and implications,” Current Opinion in Infectious Diseases, vol.
20, no. 1, pp. 3–10, 2007.
[24] C. Flateau, G. Le Loup, and G. Pialoux, “Consequences of HIV
infection on malaria and therapeutic implications: a systematic
review,”TheLancet Infectious Diseases, vol. 11, no. 7, pp. 541–556,
2011.
[25] M.K. Laufer, J. J. G. vanOosterhout, P. C.Thesing et al., “Malaria
treatment efficacy among people living with HIV: the role of
host and parasite factors,” The American Journal of Tropical
Medicine and Hygiene, vol. 77, no. 4, pp. 627–632, 2007.
[26] K. Grimwade, N. French, D. D. Mbatha, D. D. Zungu, M.
Dedicoat, and C. F. Gilks, “HIV infection as a cofactor for
severe falciparummalaria in adults living in a region of unstable
malaria transmission in South Africa,” AIDS, vol. 18, no. 3, pp.
547–554, 2004.
[27] D. M. Xiao and W. H. Bossert, “An intra-host mathematical
model on interaction between HIV and malaria,” Bulletin of
Mathematical Biology, vol. 72, no. 7, pp. 1892–1911, 2010.
[28] L. J. Abu-Raddad, P. Patnaik, and J. G. Kublin, “Dual infection
with HIV and malaria fuels the spread of both diseases in Sub-
Saharan Africa,” Science, vol. 314, no. 5805, pp. 1603–1606, 2006.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
